Benzinga's Top Upgrades

Analysts at Citigroup upgraded Biogen Idec

from “neutral” to “buy.” The target price for Biogen Idec is set to $236. Biogen Idec's shares closed at $215.20 yesterday. Analysts at Piper Jaffray upgraded Regeneron Pharmaceuticals

from “neutral” to “overweight.” The target price for Regeneron Pharmaceuticals is set to $274. Regeneron's shares closed at $224.88 yesterday. Analysts at Morgan Stanley upgraded Whitewave Foods

from “equal-weight” to “overweight.” The target price for Whitewave Foods is set to $19. Whitewave's shares closed at $16.25 yesterday. BMO Capital upgraded First Majestic Silver

from “market perform” to “outperform.” The target price for First Majestic Silver has been lowered from $18 to $13. First Majestic Silver's shares closed at $10.59 yesterday.